Stock Taper
SCREENER COMPARE ANY 2 STOCKS
UTHR
UNITED THERAPEUTICS CORPORATION
NASDAQ
$515.46
▼ DOWN 2.36% (-12.45)

KEY STATISTICS

Market Cap$21.88 B
52w High$609.35
52w Low$375.61
Dividend Yield—
Frequency—
P/E18.44
Volume266.87K
Shares Out.42.45M

COMPANY

LEADERSHIP

Martine A. Rothblatt
CHIEF EXECUTIVE
Martine A. Rothblatt

COMPENSATION 2026

Salary$1,545,005
Stock Awards$6,067,990
Incentive Plan Pay$4,281,875
All Other Comp.$68,298
Total$18,038,972

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 17, 1999
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,400

PRICE TARGET

Target High$735.00
Target Low$515.00
Target Median$662.50
Target Consensus$643.75

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$789.51M
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2009-09-23Forward2:1

PRICE

$515.46 ▼ DOWN 2.36% (−$12.45)
OVERLAYS
$516$520$524$5289:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM515.46

About United Therapeutics Corporation

https://www.unither.com ↗

United Therapeutics develops and commercializes therapies for chronic and life-threatening diseases like PAH and neuroblastoma, including inhaled, oral, and gene therapy products, with ongoing innovations and collaborations worldwide.

INDUSTRY

Biotechnology

A PRODUCT UNITED THERAPEUTICS CORPORATION IS KNOWN FOR

Tyvaso DPI (treprostinil) Inhalation Powder
Tyvaso DPI (treprostinil) Inhalation Powder

Tyvaso DPI is an FDA-approved dry powder inhaler delivering treprostinil for PAH and PH-ILD, driving revenue growth and market expansion as a key product in United Therapeutics' portfolio.

COMPETITORS

COMPETITOR
GILD COMPARE
INSM COMPARE
JNJ COMPARE
LQDA COMPARE
MRK COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Tyvaso$478M $464.3M ▼$457.5M ▼$452.6M ▼
Remodulin$125.9M $128M ▲$126.6M ▼$126.3M ▼
Orenitram$131.1M $121.2M ▼$135.6M ▲$125.7M ▼
Unituxin$47.9M $62.3M ▲$53.6M ▼$65.2M ▲
Product and Service Other$6.9M $6.6M ▼$5.3M ▼$6.8M ▲
Adcirca$9.7M $7.8M ▼$2.9M ▼$6.7M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$774.8M $752.8M ▼$744.2M ▼$733.6M ▼
NonUS$24.7M $37.4M ▲$37.3M ▼$49.7M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
663
LISTED HERE
26
RANKED BY POSITION SIZE
XUU.TO
0.03% · 1.5M
VTI
0.03% · 1.4M
AFTY
4.05% · 576.9K
UST.PA
3.06% · 491.6K
MDY
0.61% · 311.0K
XMHQ
2.48% · 266.4K
FBT
2.92% · 165.5K
SCHM
0.41% · 117.4K
DFAC
0.07% · 63.3K
JQUA
0.24% · 39.5K
JHMM
0.30% · 36.2K
PINK
4.47% · 32.6K
DSTL
0.62% · 25.3K
FLQM
0.82% · 24.5K
XO
XOVR
0.02% · 23.6K
QVAL
1.86% · 22.9K
BBH
2.31% · 21.1K
AVUS
0.08% · 20.9K
FHLC
0.28% · 18.9K
XDWH.L
0.24% · 18.6K
WTV
0.25% · 15.7K
HMWA.L
0.04% · 14.5K
GSLC
0.05% · 14.2K
GLRY
3.68% · 11.9K
NULG
0.16% · 9.7K
PB
PBPH
0.49% · 9.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
74.91%
HOLDERS
1,201
TOP 12 OF 1,201 · RANKED BY POSITION SIZE
Blackrock Inc.
5.5M sh · $1.74B
Blackrock, Inc.
5.4M sh · $3.2B
Vanguard Group Inc
4.4M sh · $1.85B
Avoro Capital Advisors LLC
2.8M sh · $1.51B
Wellington Management Group Llp
2.4M sh · $1.19B
Blackrock Fund Advisors
2.4M sh · $340.82M
Renaissance Technologies LLC
2.2M sh · $911.11M
State Street Corp
1.9M sh · $805.98M
Blackrock Institutional Trust Company, N.A.
1.4M sh · $203.75M
Aqr Capital Management LLC
1.3M sh · $624.51M
Geode Capital Management, LLC
1.2M sh · $522.91M
Janus Henderson Group Plc
866.9K sh · $514.02M

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score4

TRADES BY CONGRESS

HOUSE TRADES
Lisa McClain
Lisa McClain
Purchase
2025-06-11
 Michael McCaul
Michael McCaul
Sale
2023-05-12
 Donna Shalala
Donna Shalala
Sale (Full)
2019-03-06

INSIDER TRADES

★
DIRECTOR, OFFICER: CHAIRPERSON & CEO
ROTHBLATT MARTINE A
Purchase · 9.5K shares
2026-08-27
★
DIRECTOR, OFFICER: CHAIRPERSON & CEO
ROTHBLATT MARTINE A
Sale · 494 shares
2026-08-27
★
DIRECTOR, OFFICER: CHAIRPERSON & CEO
ROTHBLATT MARTINE A
Sale · 642 shares
2026-08-27
★
DIRECTOR, OFFICER: CHAIRPERSON & CEO
ROTHBLATT MARTINE A
Sale · 704 shares
2026-08-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
OVERWEIGHT 3
OUTPERFORM 2
NEUTRAL 1
EQUAL WEIGHT 1
11 GRADES IN THE LAST 12 MONTHS
RBC Capital OUTPERFORM JP Morgan OVERWEIGHT B of A Securities NEUTRAL Wells Fargo OVERWEIGHT Morgan Stanley EQUAL WEIGHT HC Wainwright & Co. BUY TD Cowen BUY Cantor Fitzgerald OVERWEIGHT

SECTORS PEERS

PEERPRICE
ILMN$215.59COMPARE
BIIB$218.50COMPARE
WAT$414.69COMPARE
RPRX$60.85COMPARE
DGX$242.76COMPARE
INCY$124.37COMPARE
WST$337.47COMPARE
THC$266.80COMPARE